<?xml version="1.0" encoding="UTF-8"?>
<p>Angiotensin receptor blockers (ARBs), such as losartan, valsartan, telmisartan, usually assumed for treating high blood pressure, heart and kidney failure in people with diabetes, have been recently proposed as a novel therapeutic approach to block SARS-CoV-2 RBD binding to ACE2- expressing cells binding, similarly to ACE inhibitors [
 <xref rid="B163-ijerph-17-05648" ref-type="bibr">163</xref>].
</p>
